13F Data
13F filer · CIK 924223

BB BIOTECH AG

SCHAFFHAUSEN, V8 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$2.5B
+$17.2M vs prior
Positions
30
New / sold out
3 / 2
Added / reduced
6 / 2
Turnover
2.6%
buys $89.3M · sells $66.3M
Top-10 weight
72.7%

Biggest buys vs Q1 2016

ChangeSecurityShares changeChange %Est. trade value
NewIntra-Cellular Therapies Inc.+700,000–+$27.2M
AddedAlexion Pharmaceuticals Inc.+145,000+14.0%+$16.9M
NewMacroGenics Inc.+520,000–+$14.0M
AddedAgios Pharmaceuticals Inc.+203,400+9.4%+$8.5M
AddedIonis Pharmaceuticals Inc.+325,000+4.8%+$7.6M
NewTobira Therapeutics Inc.+468,000–+$5.9M
AddedAlder Biopharmaceuticals Inc.+175,000+11.6%+$4.4M
AddedVertex Pharmaceuticals Inc.+50,000+3.7%+$4.3M
AddedSage Therapeutics Inc.+16,976+2.0%+$511.5K

Biggest sells vs Q1 2016

ChangeSecurityShares changeChange %Est. trade value
ReducedMedivation Inc.-590,000-22.9%$-35.6M
Sold outInfinity Pharmaceuticals Inc.-2,700,737-100.0%$-14.2M
Sold outClovis Oncology Inc.-528,188-100.0%$-10.1M
ReducedTesaro Inc.-75,000-6.1%$-6.3M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $1.4BQ3 2013: $1.8BQ4 2013: $1.9BQ1 2014: $1.9BQ2 2014: $2.1BQ3 2014: $2.5BQ4 2014: $3.1BQ1 2015: $3.4BQ2 2015: $3.7BQ3 2015: $3.2BQ4 2015: $3.5BQ1 2016: $2.5BQ2 2016: $2.5BQ3 2016: $2.8BQ4 2016: $2.7BQ1 2017: $3.1BQ2 2017: $3.3BQ3 2017: $3.6BQ4 2017: $3.6BQ1 2018: $3.6BQ2 2018: $3.5BQ3 2018: $3.8BQ4 2018: $3.1BQ1 2019: $4.0B
Q2 2013Q1 2019

Holdings · Q2 2016

#SecuritySharesValueWeight
1Celgene CorpCOM3,609,298$356.0M14.05%
2Incyte Corp.COM3,840,406$307.2M12.12%
3Gilead Sciences Inc.COM2,774,596$231.5M9.14%
4Ionis Pharmaceuticals Inc.COM7,104,838$165.5M6.53%
5Radius Health Inc.COM4,360,399$160.2M6.33%
6Neurocrine Biosciences Inc.COM3,121,552$141.9M5.60%
7Alexion Pharmaceuticals Inc.COM1,179,428$137.7M5.44%
8Vertex Pharmaceuticals Inc.COM1,415,445$121.8M4.81%
9Medivation Inc.COM1,991,112$120.1M4.74%
10Agios Pharmaceuticals Inc.COM2,363,321$99.0M3.91%
20 more rows. Subscribe for $29/month to see every row, download the data and use the API.